Evidence map›Paper›PMID 35406308›Full record

ArticlePolymers2022

Cyclodextrin-Oligocaprolactone Derivatives-Synthesis and Advanced Structural Characterization by MALDI Mass Spectrometry.

Cristian Peptu, Diana-Andreea Blaj, Mihaela Balan-Porcarasu, Joanna Rydz

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Cyclodextrins, Surfactants and Their Inclusion Complexes.Molecules (Basel, Switzerland) · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Mass Spectrometry of Esterified Cyclodextrins.Molecules (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Cristian PeptuPetru Poni Institute of Macromolecular Chemistry, Grigore Ghica Voda Alley, 41A, 700487 Iasi, Romania.ORCID 0000-0002-9231-0852
Diana-Andreea BlajPetru Poni Institute of Macromolecular Chemistry, Grigore Ghica Voda Alley, 41A, 700487 Iasi, Romania.
Mihaela Balan-PorcarasuPetru Poni Institute of Macromolecular Chemistry, Grigore Ghica Voda Alley, 41A, 700487 Iasi, Romania.ORCID 0000-0001-8988-070X
Joanna RydzPolish-Romanian Laboratory ADVAPOL, M. Curie-Skłodowska 34, 41-819 Zabrze, Poland and Aleea Grigore Ghica Voda, 41A, 700487 Iasi, Romania.ORCID 0000-0003-3972-7074
Institutul de Chimie Macromoleculară Petru PoniCentre of Polymer and Carbon Materials · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclodextrins have previously been proven to be active in the catalysis of cyclic ester ring-opening reactions, hypothetically in a similar way to lipase-catalyzed reactions. However, the way they act remains unclear. Here, we focus on β-cyclodextrin's involvement in the synthesis and characterization of β-cyclodextrin-oligocaprolactone (CDCL) products obtained via the organo-catalyzed ring-opening of ε-caprolactone. Previously, bulk or supercritical carbon dioxide polymerizations has led to inhomogeneous products. Our approach consists of solution polymerization (dimethyl sulfoxide and dimethylformamide) to obtain homogeneous CDCL derivatives with four monomer units on average. Oligomerization kinetics, performed by a matrix-assisted laser desorption ionization mass spectrometry (MALDI MS) optimized method in tandem with

Indexed as

biodegradable polyesterscyclodextrincyclodextrin-oligoesterkineticsMALDI mass spectrometryNMR spectroscopyring-opening oligomerizationtandem MSε-caprolactone

Identifiers

PMID35406308
PMCPMC9003485
OpenAlexW4220901920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.